Viewing Study NCT03174405


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2025-12-26 @ 2:15 AM
Study NCT ID: NCT03174405
Status: COMPLETED
Last Update Posted: 2022-09-29
First Post: 2017-05-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.
Sponsor: AIO-Studien-gGmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module